Joseph S. Shan
2014
In 2014, Joseph S. Shan earned a total compensation of $563.8K as Vice President, Clinical & Regulatory Affairs at Peregrine Pharmaceuticals, a 4% decrease compared to previous year.
Compensation breakdown
| Bonus | $67,600 |
|---|---|
| Non-Equity Incentive Plan | $68,141 |
| Option Awards | $118,140 |
| Salary | $270,400 |
| Other | $39,551 |
| Total | $563,832 |
Shan received $270.4K in salary, accounting for 48% of the total pay in 2014.
Shan also received $67.6K in bonus, $68.1K in non-equity incentive plan, $118.1K in option awards and $39.6K in other compensation.
Rankings
In 2014, Joseph S. Shan's compensation ranked 9,892nd out of 13,032 executives tracked by ExecPay. In other words, Shan earned more than 24.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,892 out of 13,032 | 24th |
Division Manufacturing | 3,754 out of 4,966 | 24th |
Major group Chemicals And Allied Products | 1,290 out of 1,686 | 24th |
Industry group Drugs | 1,029 out of 1,365 | 25th |
Industry Pharmaceutical Preparations | 789 out of 1,043 | 24th |
Source: SEC filing on August 28, 2014.
Shan's colleagues
We found five more compensation records of executives who worked with Joseph S. Shan at Peregrine Pharmaceuticals in 2014.
2014
Steven King
Peregrine Pharmaceuticals
Chief Executive Officer
2014
Paul Lytle
Peregrine Pharmaceuticals
Chief Financial Officer
2014
Jeffrey Masten
Peregrine Pharmaceuticals
Former Vice President, Quality
2014
Mark Ziebell
Peregrine Pharmaceuticals
General Counsel
2014
Shelley Fussey
Peregrine Pharmaceuticals